10-K: Aura Biosciences Details Securities and Corporate Governance in 10-K Filing

Aura Biosciences' 10-K filing outlines the company's registered securities, registration rights, anti-takeover measures, and other corporate governance details.

Summary

• Aura Biosciences has 150,000,000 authorized shares of common stock and 10,000,000 authorized shares of preferred stock, all with a par value of $0.00001 per share.
• Common stockholders are entitled to one vote per share and do not have cumulative voting rights.
• The board of directors can issue preferred stock with varying rights and preferences, which could affect common stockholders' voting power and dividend rights.
• Certain stockholders have demand, short-form, and piggyback registration rights under the Investors Rights Agreement dated March 18, 2021.
• The company is obligated to cover the costs of underwritten registrations, while selling expenses are borne by the selling stockholders.
• Demand registration rights terminate on November 2, 2026, or upon a liquidation event, or when a stockholder can sell all shares under Rule 144.
• The company's certificate of incorporation and bylaws include anti-takeover provisions, such as a classified board, removal of directors only for cause, and no written consent of stockholders.
• Stockholder actions require a vote at an annual or special meeting, and special meetings can only be called by a majority of the board.
• Amendments to the certificate of incorporation require board approval and a majority vote of outstanding shares, with certain provisions requiring a two-thirds vote.
• The bylaws can be amended by a majority of directors or a majority of outstanding shares, with certain provisions requiring a two-thirds vote.
• The company's bylaws designate the Delaware Court of Chancery as the exclusive forum for certain state law claims and the federal district courts for Securities Act claims.
• The company is subject to Section 203 of the Delaware General Corporation Law, which restricts business combinations with interested stockholders.
• The company's common stock is listed on the Nasdaq Global Market under the symbol AURA.
• Computershare Trust Company, N.A. is the transfer agent and registrar for the common stock.

Sentiment

Score: 6

Explanation: The document is neutral in tone, providing factual information about the company's securities and governance. It does not contain any positive or negative sentiment.

Positives

• The document provides a clear outline of the company's capital structure and stockholder rights.
• Registration rights offer liquidity options for certain stockholders.
• The company's governance structure is clearly defined.
• The document provides details on the company's listing on the Nasdaq Global Market.

Negatives

• The anti-takeover provisions could make it difficult for stockholders to influence the company's direction.
• The board's ability to issue preferred stock could dilute common stockholders' voting power and dividend rights.
• The exclusive forum provisions may limit stockholders' ability to bring claims in a favorable forum.

Risks

• The issuance of preferred stock could adversely affect the voting power and dividend rights of common stockholders.
• Anti-takeover provisions may discourage potential acquirers and limit stockholders' ability to change management.
• The exclusive forum provisions may impose additional costs on stockholders and limit their ability to bring claims in a favorable forum.
• Section 203 of the Delaware General Corporation Law could restrict business combinations with interested stockholders.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but it does outline the company's capital structure and governance, which are important for future operations.

Industry Context

This document is a standard 10-K filing, which is a common practice for publicly traded companies. The details provided are typical for a company in the biotechnology sector.

Comparison to Industry Standards

• The capital structure and governance provisions outlined in this document are typical for a publicly traded company in the biotechnology sector.
• Many companies in this sector have similar registration rights agreements with their major investors.
• Anti-takeover provisions are also common in corporate charters and bylaws to protect the company from hostile takeovers.
• The exclusive forum provisions are increasingly common in corporate bylaws to manage litigation risks.

Stakeholder Impact

• Shareholders are impacted by the voting rights and potential dilution from preferred stock issuance.
• Investors with registration rights have liquidity options.
• Potential acquirers are impacted by the anti-takeover provisions.
• All stakeholders are impacted by the governance structure and legal framework.

Key Dates

Keywords

common stock, preferred stock, registration rights, anti-takeover, corporate governance, Delaware law, Nasdaq, voting rights, board of directors, bylaws